MétaCan
Menu
Cohort builder

4,299,418 works, Canadian by any of four routes.

Every filter state is a URL; the URL is the query; the query is citable via /q/⟨hash⟩. The page, the API and the export parse the same parameters.

The current cohort, streamed from the database: every work column, the machine labels, the provisional scores, and the per-row validation status. Exports are capped at 100,000 rows. Mints a permanent /q/ link for this exact query. The same filters always produce the same link, whoever asks.

Search term
Author
Year range
Sort
Language
Type
Field
Venue
Topic
Pharmaceutical Economics and Policy
Retraction
Abstract
Evidence source
Study design
Label agreement
Label status

Direct Codex and Gemma labels are unvalidated and sparse. Distilled predictions cover the full frame and are also unvalidated. Choose the evidence source explicitly; absence of a direct label is never a negative label.

affaffiliation
fundfunder
venuejournal
aboutaboutness

The four routes compose: require the funder route and exclude affiliation to get the funder-only stratum no affiliation-based frame ever sees.

1,682 results · 1 filter active ·
Results by year
20002025
Publication date
Categories
Machine labels · sparse coverage
Evidence
Language
Type
Citations
An unlabeled work is unknown, not a negative. Label coverage is reported on every query.
1,682 works in the cohort · of 4,299,418page 19 of 34

Labels cover 5 of 1,682 works in this cohort. The rest are unlabeled, which is not a negative label: the label table is sparse today and grows as labeling rounds land.

Distilled predictions cover 1,682 of 1,682 works in this cohort. Predictions are machine_predicted_unvalidated. The Gemma side is a direct model label for every work (title-only); the Codex side is a distilled, calibrated classifier. Candidate is the union; consensus is the intersection.

aboutno affno abstractunlabeled
Canada DrugBank
2020· reference-entry· en· Definitions· Economics, Econometrics and Finance
machine prediction:candidate · insufficient_payloadconsensus · none
1
citations
aboutno affunlabeled
Les risques liés à la création de PHARMA-QUEBEC
Claude Montmarquette, Stéphanie Boulenger, Joanne Castonguay
2014· preprint· fr· RePEc: Research Papers in Economics· Economics, Econometrics and Finance
machine prediction:candidate · noneconsensus · none
1
citations
affunlabeled
Making Sure Orphan Drugs Don’t Get Left Behind
G. Kent Fellows, Daniel J. Dutton, Aidan Hollis
2018· article· en· RePEc: Research Papers in Economics· Economics, Econometrics and Finance
machine prediction:candidate · noneconsensus · none
1
citations
aboutno affunlabeled
The politics of the EU pharmaceutical industry
Govin Permanand, Christa Alt̀enstetter
2004· book-chapter· en· London School of Economics and Political Science Research Online (London School of Economics and Political Science)· Economics, Econometrics and Finance
machine prediction:candidate · noneconsensus · none
1
citations
aboutno affno abstractunlabeled
Canadian drug reimportation debate goes on
Nicole L. Johnson
2005· article· en· Drug Discovery Today· Economics, Econometrics and Finance
machine prediction:candidate · noneconsensus · none
1
citations
venueaboutno affno abstractunlabeled
Alberta also moving into pharmacy technician regulation
Kathie Lynas
2011· article· en· Canadian Pharmacists Journal / Revue des Pharmaciens du Canada· Economics, Econometrics and Finance
machine prediction:candidate · noneconsensus · none
1
citations
affno abstractunlabeled
Drug hunters incorporated! Is there a formula?
Youssef L. Bennani
2014· editorial· en· Drug Discovery Today· Economics, Econometrics and Finance
machine prediction:candidate · noneconsensus · none
1
citations
venueno affunlabeled
Comparison shopping for drugs
Ludwig Vogel
2011· article· en· Canadian Medical Association Journal· Economics, Econometrics and Finance
machine prediction:candidate · insufficient_payloadconsensus · none
1
citations
venueno affno abstractunlabeled
Competition Bureau shouldn't point finger at pharmacies
Rob Fursiewicz
2008· article· en· Canadian Pharmacists Journal / Revue des Pharmaciens du Canada· Economics, Econometrics and Finance
machine prediction:candidate · noneconsensus · none
1
citations
affno abstractunlabeled
Longer Exclusivity Does Not Guarantee Better Drugs
Donald W. Light, Joel Lexchin, Jörg Schaaber
2011· letter· en· Health Affairs· Economics, Econometrics and Finance
machine prediction:candidate · noneconsensus · none
1
citations
affvenueunlabeled
A survey of regulatory recommendations for waivers of in vivo bioequivalence studies of generic products for certain dosage forms by participating regulators and organisations of the International Pharmaceutical Regulators Programme. Part 2
Alfredo García‐Arieta, Andrew Tam, Florencia Tiseyra, Eduardo Agostinho Freitas Fernandes, Kelen Carine Costa Soares, Henrike Potthast +31 more
2025· review· en· Journal of Pharmacy & Pharmaceutical Sciences· Economics, Econometrics and Finance
machine prediction:candidate · noneconsensus · none
1
citations
venueno affunlabeled
Recognize the Role of Employers
Marg French
2004· letter· en· A Nudge Too Far? A Nudge at All? On Paying People to Be Healthy· Economics, Econometrics and Finance
machine prediction:candidate · noneconsensus · none
1
citations
affno abstractunlabeled
Association between Industry Payments and Prescription of Inhaled Medications
Hasan Nadeem, Lucas M. Donovan, Laura C. Feemster, David H. Au, William B. Feldman, Kevin I. Duan
2025· letter· en· American Journal of Respiratory and Critical Care Medicine· Economics, Econometrics and Finance
machine prediction:candidate · metaresearchconsensus · none
1
citations
venueaboutno affno abstractunlabeled
Threat to Canada's drug supply recedes – CPhA
Kathie Lynas
2007· article· en· Canadian Pharmacists Journal / Revue des Pharmaciens du Canada· Economics, Econometrics and Finance
machine prediction:candidate · noneconsensus · none
1
citations

How this was built: Screen · Findings · About